Gary Taylor
Stock Analyst at TD Cowen
(1.99)
# 3,172
Out of 5,106 analysts
148
Total ratings
50.51%
Success rate
-0.27%
Average return
Main Sectors:
Stocks Rated by Gary Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Buy | $44 → $25 | $14.28 | +75.07% | 5 | Aug 7, 2025 | |
| BBWI Bath & Body Works | Maintains: Buy | $40 → $42 | $20.05 | +109.48% | 2 | Nov 26, 2024 | |
| PIII P3 Health Partners | Maintains: Hold | $45 → $13 | $5.19 | +140.93% | 2 | Nov 20, 2024 | |
| AGL agilon health | Maintains: Hold | $6 → $2 | $0.72 | +178.16% | 4 | Nov 11, 2024 | |
| HUM Humana | Maintains: Hold | $261 → $268 | $268.45 | -0.17% | 20 | Nov 4, 2024 | |
| ALHC Alignment Healthcare | Maintains: Buy | $10 → $13 | $19.36 | -32.85% | 6 | Oct 31, 2024 | |
| HCA HCA Healthcare | Maintains: Buy | $450 → $440 | $484.77 | -9.24% | 9 | Oct 28, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $601 → $609 | $341.84 | +78.15% | 4 | Oct 18, 2024 | |
| CNC Centene | Maintains: Buy | $80 → $89 | $40.85 | +117.87% | 10 | Jul 31, 2024 | |
| MOH Molina Healthcare | Maintains: Buy | $351 → $378 | $168.50 | +124.33% | 18 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $183 → $220 | $222.60 | -1.17% | 12 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $139 → $150 | $121.35 | +23.61% | 11 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $26 | $24.91 | +4.38% | 5 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $39 → $35 | $15.63 | +123.93% | 2 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $564 → $585 | $359.07 | +62.92% | 2 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $6 | $16.63 | -63.92% | 1 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 → $8 | $6.91 | +15.77% | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $242 → $329 | $274.70 | +19.77% | 3 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | $7 → $3 | $2.70 | +11.11% | 4 | Feb 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $17 | $5.40 | +214.81% | 1 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $28 → $20 | $199.40 | -89.97% | 12 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $20 | $22.50 | -11.11% | 6 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.24 | - | 6 | Dec 14, 2017 |
Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44 → $25
Current: $14.28
Upside: +75.07%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $42
Current: $20.05
Upside: +109.48%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45 → $13
Current: $5.19
Upside: +140.93%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6 → $2
Current: $0.72
Upside: +178.16%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261 → $268
Current: $268.45
Upside: -0.17%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10 → $13
Current: $19.36
Upside: -32.85%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450 → $440
Current: $484.77
Upside: -9.24%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601 → $609
Current: $341.84
Upside: +78.15%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80 → $89
Current: $40.85
Upside: +117.87%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351 → $378
Current: $168.50
Upside: +124.33%
Jul 26, 2024
Maintains: Hold
Price Target: $183 → $220
Current: $222.60
Upside: -1.17%
Jul 24, 2024
Maintains: Hold
Price Target: $139 → $150
Current: $121.35
Upside: +23.61%
Mar 1, 2024
Maintains: Outperform
Price Target: $30 → $26
Current: $24.91
Upside: +4.38%
Nov 14, 2023
Upgrades: Outperform
Price Target: $39 → $35
Current: $15.63
Upside: +123.93%
Jul 24, 2023
Maintains: Outperform
Price Target: $564 → $585
Current: $359.07
Upside: +62.92%
Feb 14, 2023
Maintains: Market Perform
Price Target: $3 → $6
Current: $16.63
Upside: -63.92%
Nov 14, 2022
Maintains: Outperform
Price Target: $10 → $8
Current: $6.91
Upside: +15.77%
May 9, 2022
Upgrades: Outperform
Price Target: $242 → $329
Current: $274.70
Upside: +19.77%
Feb 2, 2022
Upgrades: Market Perform
Price Target: $7 → $3
Current: $2.70
Upside: +11.11%
Sep 10, 2021
Initiates: Market Perform
Price Target: $17
Current: $5.40
Upside: +214.81%
Sep 21, 2020
Downgrades: Underweight
Price Target: $28 → $20
Current: $199.40
Upside: -89.97%
Feb 24, 2020
Maintains: Neutral
Price Target: $33 → $20
Current: $22.50
Upside: -11.11%
Dec 14, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.24
Upside: -